New patent for Galderma Labs drug SOOLANTRA

   June 24, 2021    Comments Off on New patent for Galderma Labs drug SOOLANTRA    Posted in: Patent Added

Annual Drug Patent Expirations for SOOLANTRA Soolantra is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from three suppliers. There are eleven…

The post New patent for Galderma Labs drug SOOLANTRA appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog